Averin Capital Acquisition Corp. (ACAA)
| Market Cap | 314.50M |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 31.45M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ACAA
Averin Capital Acquisition is a blank check company incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on the ability of our management team to identify, acquire and manage a business at the intersection of technology and health that can benefit from our operational expertise.
News
Averin Capital Acquisition Corp. Announces the Pricing of $250,000,000 Initial Public Offering
New York, NY, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 25,000,000 units at a price of $10.00 per...
Averin Capital Acquisition IPO Registration Document (S-1)
Averin Capital Acquisition has filed to go public with an IPO on the NASDAQ
SPAC Averin Capital Acquisition files for a $250 million IPO, targeting health and life sciences sectors
Averin Capital Acquisition, a blank check company targeting health and life sciences, filed on Friday with the SEC to raise up to $250 million in an initial public offering.